Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

ClinicalTrials.gov ID: NCT02943564

Public ClinicalTrials.gov record NCT02943564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Study identification

NCT ID
NCT02943564
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
658 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2016 (Actual)
Primary completion
Dec 12, 2018 (Actual)
Completion
Dec 18, 2018 (Actual)
Last update posted
Dec 27, 2019

2016 – 2018

United States locations

U.S. sites
66
U.S. states
24
U.S. cities
59
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of Arizona Department of Psychiatry Tucson Arizona 85724 —
Woodland International Research Group Little Rock Arkansas 72211 —
Woodland Research Northwest Rogers Arkansas 72758 —
California Pharmaceutical Research Institute, Inc Anaheim California 92804 —
ProScience Research Group Culver City California 90230 —
Behavioral Research Specialists, LLC Glendale California 91206 —
Synergy Clinical Research Center of Escondido Lemon Grove California 91945 —
Pacific Research Partners; LLC. Oakland California 94607 —
CITrials Riverside California 92506 —
Artemis Institute for Clinical Research San Diego California 92103 —
PCSD Feighner Research San Diego California 92108 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Reliable Clinical Research Hialeah Florida 33012 —
Advanced Research Institute of Miami Homestead Florida 33030 —
Innovative Clinical Research, Inc Lauderhill Florida 33319 —
International Research Associates, LLC Miami Florida 33183 —
Sarkis Clinical Trials Ocala Florida 34474 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Clinical Neuroscience Solutions, Inc Orlando Florida 32801 —
Millenia Psychiatry & Research, Inc Orlando Florida 32839 —
iResearch Atlanta, LLC Decatur Georgia 30030 —
IRIS Research Smyrna Georgia 30080 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Capstone Clinical Research Libertyville Illinois 60048 —
Phoenix Medical Research Prairie Village Kansas 66208 —
Heartland Research Associates Wichita Kansas 67207 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
J Gary Booker, MD APMC Shreveport Louisiana 71104 —
Pharmasite Research, Inc Baltimore Maryland 21208 —
CBH Health Rockville Maryland 20850 —
Boston Clinical Trials Boston Massachusetts 02131 —
ActivMed Practices & Research, Inc. Methuen Massachusetts 01844 —
BTC of New Bedford New Bedford Massachusetts 02740 —
Coastal Research Associates Weymouth Massachusetts 02190 —
Precise Research Centers Flowood Mississippi 39232 —
Millennium Psychiatric Associates Olivette Missouri 63132 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Pharmaceutical Research Associates Inc Marlton New Jersey 08053 —
The Medical Research Network, LLC New York New York 10128 —
Richmond Behavioral Associates Staten Island New York 10312 —
Richard H. Weisler, MD, PA Raleigh North Carolina 27609 —
Patient Priority Clinical Site, LLC Cincinnati Ohio 45215 —
The Ohio State University Department of Psychiatry Columbus Ohio 43210 —
Charak Clinical Research Center Garfield Heights Ohio 44125 —
Lindner Center of Hope Mason Ohio 45040 —
Professional Psychiatric Services Mason Ohio 45040 —
Red River Medical Research Center, LLC Oklahoma City Oklahoma 73112 —
Sooner Clinical Research, Inc Oklahoma City Oklahoma 73112 —
Paradigm Research Professionals Oklahoma City Oklahoma 73118 —
Summit Research Network Portland Oregon 97210 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18104 —
Suburban Research Associates Media Pennsylvania 19063 —
Carolina Clinical Trials, Inc. Charleston South Carolina 29407 —
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464 —
Community Clinical Research, Inc. Austin Texas 78754 —
BioBehavioral Research of Austin Austin Texas 78759 —
Relaro Medical Trials Dallas Texas 75243 —
El Campo Clinical Trials El Campo Texas 77347 —
Earle Research Houston Texas 77058 —
Red Oak Psychiatry Associates, PA Houston Texas 77090 —
Family Psychiatry of The Wood The Woodlands Texas 77381 —
PRA Health Sciences Salt Lake City Utah 84106 —
Pacific Institute of Medical Sciences Bothell Washington 98011 —
Eastside Therapeutic Resource Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02943564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 27, 2019 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02943564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →